SHANGHAI, China, May 21 WuXi PharmaTech (NYSE: WX),a leading pharmaceutical, biotechnology and medical device research anddevelopment outsourcing company with operations in China and the United States,is proud to announce that the distinguished Stanford University ProfessorBarry M. Trost ( http://www.stanford.edu/group/bmtrost/ ) has visited WuXiPharmaTech and given two seminars on May 19 and 20.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
Dr. Barry M. Trost, Tamaki Professor of Humanities and Sciences in thechemistry department at Stanford University, is a world renowned organicchemist and a fellow of the U.S. National Academy of Sciences. ProfessorBarry M. Trost's professional interests include asymmetric allylic alkylationand efficient enantioselective synthesis. He has made great contributions tothe modern synthetic organic chemistry and green chemistry. Many widely usedchemistry reactions, such as the Trost asymmetric allylic alkylation,Tsuji-Trost reaction and the Trost ligand, are named after him.
Professor Trost studied at the University of Pennsylvania and received hisPh.D. from the Massachusetts Institute of Technology in 1965. He was aprofessor at the University of Wisconsin-Madison from 1965 until hisappointment to Stanford University in 1987. Professor Trost has more than 820scientific publications, over 320 lectures at various national andinternational meetings, and over 40 worldwide awards and honors.
As another luminary speaker of WuXi PharmaTech Science Seminar Series,Professor Trost gave the WuXi scientists two lectures titled "New SyntheticStrategies to Bioactive Products" and "On Inventing Reactions for AtomEconomy." Professor Trost captivated the audience from beginning to endduring the lectures and answered questions from the packed crowd.
"This is my first time to give a lecture to a pharmaceutical servicecompany in China. I am very impressed by WuXi's Science Seminar Series programas well as the research capability and scientific acumen of WuXi's youngscientists. Talents are absolutely the key to success for any business,especially for WuXi which provides high quality research and developmentservices to global life science companies," commented Professor Barry M. Trost.
"We are very privileged to have Dr. Trost share his brilliant expertisewith our young scientists," commented Dr. Ge Li, Chairman and Chief ExecutiveOfficer of WuXi PharmaTech. "As we broaden our R&D service scope our successvery much depends on the quality of our scientists. Investing in people is andwill continue to be one of our top strategies."
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech providespharmaceutical, biotechnology and medical device companies a broad andintegrated portfolio of laboratory and manufacturing services throughout thedrug and medical device R&D process. WuXi PharmaTech's services are designedto assist its global partners in shortening the cycle and lowering the cost ofdrug and medical device R&D. For more information, please visit:http://www.wuxipharmatech.com .For more information, please contact: Sherry Shao Tel: +86-21-5046-4002 Email: [email protected]
SOURCE WuXi PharmaTech